Review
Assessment of Chimeric Mice with Humanized Liver as a Tool for Predicting Circulating Human Metabolites

https://doi.org/10.2133/dmpk.25.223Get rights and content

Summary:

The ability to predict circulating human metabolites of a candidate drug before first-in-man studies are carried out would provide a clear advantage in drug development. A recent report demonstrated that while in vitro studies using human liver preparations reliably predict primary human metabolites in plasma, the predictability of secondary metabolites, formed by multiple reactions, was low, with total success rates of < 65%. Here, we assess the use of chimeric mice with humanized liver as an animal model for the prediction of human metabolism in vivo. Metabolism studies with debrisoquine and (S)-warfarin demonstrated significantly higher concentrations of their primary human abundant metabolites in serum or plasma in chimeric mice than in control mice. Humanized chimeric mice were also capable of producing human-specific metabolites of several in-house compounds which were generated through more than one metabolism reaction. This model is closer to in vivo human physiology and therefore appears to have an advantage over in vitro systems in predicting complex metabolites in human plasma. However, prediction of human metabolites failed for other compounds which were highly metabolized in mice. Although requiring careful consideration of compound suitability, this model represents a potential tool for predicting human metabolites in combination with conventional in vitro systems.

References (60)

  • H. Yamazaki et al.

    Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R-and S-warfarin enantiomers

    Biochem. Pharmacol.

    (1997)
  • A. Guillouzo et al.

    Maintenance of cytochrome P-450 in cultured adult human hepatocytes

    Biochem. Pharmacol.

    (1985)
  • N. Mizuno et al.

    Drug transporters: their role and importance in the selection and development of new drugs

    Drug Metab. Pharmacokinet.

    (2002)
  • T. Inoue et al.

    Prediction of human disposition toward S-3H-warfarin using chimeric mice with humanized liver

    Drug Metab. Pharmacokinet.

    (2009)
  • S.A. Wrighton et al.

    The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies

    Toxicol. Pathol.

    (1995)
  • D.A. Smith et al.

    Metabolites and safety: What are the concerns, and how should we address them?

    Chem. Res. Toxicol.

    (2006)
  • Food and Drug Administration

    Guidance for Industry: Safety Testing of Drug Metabolites

    (2008)
  • Food and Drug Administration

    Guidance for Industry: M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals

    (2010)
  • L. Leclercq et al.

    Which human metabolites have we MIST? Retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development

    Chem. Res. Toxicol.

    (2009)
  • A.N.R. Nedderman

    Metabolites in safety testing: metabolite identification strategies in discovery and development

    Biopharm. Drug Dispos.

    (2009)
  • M. Zhu et al.

    Integrated strategies for assessment of metabolite exposure in humans during drug development: analytical challenges and clinical development considerations

    Biopharm. Drug Dispos.

    (2009)
  • S. Anderson et al.

    Predicting circulating human metabolites: how good are we?

    Chem. Res. Toxicol.

    (2009)
  • D. Dalvie et al.

    Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites

    Chem. Res. Toxicol.

    (2009)
  • M. Katoh et al.

    Application of chimeric mice with humanized liver for predictive ADME

    Drug Metab. Rev.

    (2007)
  • H. Yamazaki et al.

    Approach for in vivo protein binding of 5-n-butyl-pyrazolo[1,5-a]pyrimidine bioactivated in chimeric mice with humanized liver by two-dimensional electrophoresis with accelerator mass spectrometry

    Chem. Res. Toxicol.

    (2010)
  • J.A. Rhim et al.

    Replacement of diseased mouse liver by hepatic cell transplantation

    Science

    (1994)
  • J.A. Rhim et al.

    Complete reconstitution of mouse liver with xenogeneic hepatocytes

    Proc. Natl. Acad. Sci. U.S.A.

    (1995)
  • J. Petersen et al.

    Liver repopulation with xenogenic hepatocytes in B and T celldeficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma

    Proc. Natl. Acad. Sci. U.S.A.

    (1998)
  • J.J. Brown et al.

    A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice

    Hepatology

    (2000)
  • D.F. Mercer et al.

    Hepatitis C virus replication in mice with chimeric human livers

    Nat. Med.

    (2001)
  • Cited by (0)

    View full text